Cell context reveals a dual role for Maf in oncogenesisPOUPONNOT, C; SII-FELICE, K; HMITOU, I et al.Oncogene (Basingstoke). 2006, Vol 25, Num 9, pp 1299-1310, issn 0950-9232, 12 p.Article

Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic FormRAGO, Angela; GRAMMATICO, Sara; LA VERDE, Giacinto et al.Cancer. 2012, Vol 118, Num 22, pp 5544-5549, issn 0008-543X, 6 p.Article

Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma : emphasis on risk factors for progressionKYLE, Robert A; RAJKUMAR, S. Vincent.British journal of haematology. 2007, Vol 139, Num 5, pp 730-743, issn 0007-1048, 14 p.Article

Comparative genomic hybridisation identifies two variants of smoldering multiple myelomaROSINOL, Laura; CARRIO, Ana; BLADE, Joan et al.British journal of haematology. 2005, Vol 130, Num 5, pp 729-732, issn 0007-1048, 4 p.Article

Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patientsPAIVA, B; GUTIERREZ, N.-C; DIAZ-RODRIGUEZ, E et al.Leukemia. 2012, Vol 26, Num 8, pp 1862-1869, issn 0887-6924, 8 p.Article

Identification of ID-1 as a potential target gene of MMSET in multiple myelomaHUDLEBUSCH, Heidi Rye; THEILGAARD-MÖNCH, Kim; LODAHL, Marianne et al.British journal of haematology. 2005, Vol 130, Num 5, pp 700-708, issn 0007-1048, 9 p.Article

Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cellsBRITO, Jose L. R; DAVIES, Faith E; GONZALEZ, David et al.Journal of immunological methods. 2008, Vol 333, Num 1-2, pp 147-155, issn 0022-1759, 9 p.Article

Radiotherapy for a destructive cervicothoracic lesion from multiple myeloma Case illustrationTATSUI, Claudio E; RAO, Ganesh; RHINES, Laurence D et al.Journal of neurosurgery. Spine. 2007, Vol 6, Num 5, pp 493-493, issn 1547-5654, 1 p.Article

Fe₃O₄ nanoparticle loaded paclitaxel induce multiple myeloma apoptosis by cell cycle arrest and increase cleavage of caspases in vitroCUIPING YANG; XIANGFENG HE; JUNSONG CHEN et al.Journal of nanoparticle research. 2013, Vol 15, Num 8, issn 1388-0764, 1840.1-1840.13Article

Early response to therapy and survival in multiple myelomaSCHAAR, C. G; KLUIN-NELEMANS, J. C; LE CESSIE, S et al.British journal of haematology. 2004, Vol 125, Num 2, pp 162-166, issn 0007-1048, 5 p.Article

Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-α signaling complexWALTERS, Denise K; FRENCH, Jena D; ARENDT, Bonnie K et al.Oncogene (Basingstoke). 2003, Vol 22, Num 23, pp 3598-3607, issn 0950-9232, 10 p.Article

IL-6-independent expression of Mcl-1 in human multiple myelomaBIN ZHANG; POTYAGAYLO, Valeria; FENTON, Robert G et al.Oncogene (Basingstoke). 2003, Vol 22, Num 12, pp 1848-1859, issn 0950-9232, 12 p.Article

Heat insoluble cryoglobulin associated with gangrene in multiple myelomaMODARRESSI, Amir; KURIYAN, Mercy; HARVEY, Gail et al.Journal of clinical apheresis (Print). 2003, Vol 18, Num 4, pp 190-193, issn 0733-2459, 4 p.Article

Analysis of histone deacetylase inhibitor, depsipeptide (fr901228), effect on multiple myelomaKHAN, S. B; MAUDUDI, T; BARTON, K et al.British journal of haematology. 2004, Vol 125, Num 2, pp 156-161, issn 0007-1048, 6 p.Article

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma Working GroupBritish journal of haematology. 2003, Vol 121, Num 5, pp 749-757, issn 0007-1048, 9 p.Article

AL amyloidosis or multiple myeloma? An important distinctionFALK, Rodney H.British journal of haematology. 2014, Vol 164, Num 5, pp 748-749, issn 0007-1048, 2 p.Article

Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myelomaRIBATTI, D; NICO, B; VACCA, A et al.Oncogene (Basingstoke). 2006, Vol 25, Num 31, pp 4257-4266, issn 0950-9232, 10 p.Article

Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease statusYEH, Howard S; HAIMING CHEN; MA, Jonathan et al.British journal of haematology. 2006, Vol 133, Num 5, pp 526-529, issn 0007-1048, 4 p.Article

Extramedullary multiple myeloma escapes the effect of thalidomideROSINOL, Laura; CIBEIRA, M. Teresa; BLADE, Joan et al.Haematologica (Roma). 2004, Vol 89, Num 7, pp 832-836, issn 0390-6078, 5 p.Article

Proteomic analysis of multiple myeloma: Current status and future perspectivesFENG GE; BI, Li-Jun; TAO, Sheng-Ce et al.Proteomics. Clinical applications (Print). 2011, Vol 5, Num 1-2, pp 30-37, issn 1862-8346, 8 p.Article

A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effectROZEMULLER, Henk; VAN DER SPEK, Ellen; MUTIS, Tuna et al.Haematologica (Roma). 2008, Vol 93, Num 7, pp 1049-1057, issn 0390-6078, 9 p.Article

Comparative proteomic analysis to discover potential therapeutic targets in human multiple myelomaXIAO, Chuan-Le; ZHANG, Zhi-Ping; SHENG XIONG et al.Proteomics. Clinical applications (Print). 2009, Vol 3, Num 11, pp 1348-1360, issn 1862-8346, 13 p.Article

Multiple complications in multiple myelomaBASI, Seema; SCHULMAN, Gerald; FOGO, Agnes B et al.American journal of kidney diseases. 2005, Vol 45, Num 3, pp 619-623, issn 0272-6386, 5 p.Article

Novel therapies in MM: from the aspect of preclinical studies : PIH: Understanding the Pathogenesis and the Evolving Treatment Paradigm for Multiple Myeloma in the Era of Novel AgentsHIDESHIMA, Teru; ANDERSON, Kenneth C.International journal of hematology. 2011, Vol 94, Num 4, pp 344-354, issn 0925-5710, 11 p.Article

Phosphoproteomic analysis of primary human multiple myeloma cellsFENG GE; XIAO, Chuan-Le; YIN, Xing-Feng et al.Journal of proteomics (Print). 2010, Vol 73, Num 7, pp 1381-1390, issn 1874-3919, 10 p.Article